REFERENCES
1. Shen W-K, Sheldon RS, Benditt DG, et al. 2017 ACC/AHA/HRS Guideline
for the Evaluation and Management of Patients With Syncope. A
Report of the American College of Cardiology/American Heart Association
Task Force on Clinical Practice Guidelines and the Heart Rhythm
Society . 2017;70(5):e39-e110. doi:10.1016/j.jacc.2017.03.003
2. Brignole M, Moya A, de Lange FJ, et al. 2018 ESC Guidelines for the
diagnosis and management of syncope. European Heart Journal .
2018;39(21):1883-1948. doi:10.1093/eurheartj/ehy037
3. Ruwald MH, Hansen ML, Lamberts M, et al. The relation between age,
sex, comorbidity, and pharmacotherapy and the risk of syncope: a Danish
nationwide study. Europace : European pacing, arrhythmias, and
cardiac electrophysiology : journal of the working groups on cardiac
pacing, arrhythmias, and cardiac cellular electrophysiology of the
European Society of Cardiology . Oct 2012;14(10):1506-14.
doi:10.1093/europace/eus154
4. Sun BC, Emond JA, Camargo CA, Jr. Characteristics and admission
patterns of patients presenting with syncope to U.S. emergency
departments, 1992-2000. Academic emergency medicine : official
journal of the Society for Academic Emergency Medicine . Oct
2004;11(10):1029-34. doi:10.1197/j.aem.2004.05.032
5. Ruwald MH, Hansen ML, Lamberts M, et al. Accuracy of the ICD-10
discharge diagnosis for syncope. Europace : European pacing,
arrhythmias, and cardiac electrophysiology : journal of the working
groups on cardiac pacing, arrhythmias, and cardiac cellular
electrophysiology of the European Society of Cardiology . Apr
2013;15(4):595-600. doi:10.1093/europace/eus359
6. Olde Nordkamp LR, van Dijk N, Ganzeboom KS, et al. Syncope prevalence
in the ED compared to general practice and population: a strong
selection process. The American journal of emergency medicine .
Mar 2009;27(3):271-9. doi:10.1016/j.ajem.2008.02.022
7. van Dijk N, Sprangers MA, Colman N, Boer KR, Wieling W, Linzer M.
Clinical factors associated with quality of life in patients with
transient loss of consciousness. Journal of cardiovascular
electrophysiology . Sep 2006;17(9):998-1003.
doi:10.1111/j.1540-8167.2006.00533.x
8. Sun BC. Quality-of-life, health service use, and costs associated
with syncope. Progress in cardiovascular diseases . Jan-Feb
2013;55(4):370-5. doi:10.1016/j.pcad.2012.10.009
9. Linzer M, Pontinen M, Gold DT, Divine GW, Felder A, Brooks WB.
Impairment of physical and psychosocial function in recurrent syncope.Journal of clinical epidemiology . 1991;44(10):1037-43.
10. Jorge JG, Raj SR, Teixeira PS, Teixeira JAC, Sheldon RS. Likelihood
of injury due to vasovagal syncope: a systematic review and
meta-analysis. EP Europace . 2021;23(7):1092-1099.
doi:10.1093/europace/euab041 %J EP Europace
11. Sun BC, Emond JA, Camargo CA, Jr. Direct medical costs of
syncope-related hospitalizations in the United States. The
American journal of cardiology . Mar 1 2005;95(5):668-71.
doi:10.1016/j.amjcard.2004.11.013
12. Aminorroaya A, Tavolinejad H, Sadeghian S, et al. Comparison of
Outcomes with Midodrine and Fludrocortisone for Objective Recurrence in
Treating Syncope (COMFORTS trial): Rationale and design for a
multi-center randomized controlled trial. American Heart Journal .
2021/07/01/ 2021;237:5-12.
doi:https://doi.org/10.1016/j.ahj.2021.03.002
13. Tavolinejad H, Poopak A, Sadeghian S, et al. Compression stockings
for treating vasovagal syncope (COMFORTS-II) trial: Rationale and design
of a triple-blind, multi-center, randomized controlled trial.American Heart Journal . 2022/07/01/ 2022;249:57-65.
doi:https://doi.org/10.1016/j.ahj.2022.04.002
14. Benditt DG, Ermis C, Padanilam B, Samniah N, Sakaguchi S.
Catecholamine response during haemodynamically stable upright posture in
individuals with and without tilt-table induced vasovagal syncope.Europace : European pacing, arrhythmias, and cardiac
electrophysiology : journal of the working groups on cardiac pacing,
arrhythmias, and cardiac cellular electrophysiology of the European
Society of Cardiology . Jan 2003;5(1):65-70.
15. Goldstein DS, Holmes C, Frank SM, et al. Sympathoadrenal imbalance
before neurocardiogenic syncope. The American journal of
cardiology . Jan 1 2003;91(1):53-8.
16. Alboni P, Dinelli M, Gruppillo P, et al. Haemodynamic changes early
in prodromal symptoms of vasovagal syncope. Europace : European
pacing, arrhythmias, and cardiac electrophysiology : journal of the
working groups on cardiac pacing, arrhythmias, and cardiac cellular
electrophysiology of the European Society of Cardiology . Jul
2002;4(3):333-8.
17. Olgunturk R, Turan L, Tunaoglu FS, et al. Abnormality of the left
ventricular sympathetic nervous function assessed by I-123
metaiodobenzylguanidine imaging in pediatric patients with
neurocardiogenic syncope. Pacing and clinical electrophysiology :
PACE . Oct 2003;26(10):1926-30.
18. Vanderheyden M, Goethals M, Nellens P, Andries E, Brugada P.
Different humoral responses during head-up tilt testing among patients
with neurocardiogenic syncope. Am Heart J . Jan 1998;135(1):67-73.
19. Sra JS, Murthy V, Natale A, et al. Circulatory and catecholamine
changes during head-up tilt testing in neurocardiogenic (vasovagal)
syncope. The American journal of cardiology . Jan 1
1994;73(1):33-7.
20. Richard Harvey DF. Lippincott’s Illustrated Reviews:
Biochemistry . fifth ed. 2011.
21. Huotari M, Gogos JA, Karayiorgou M, et al. Brain catecholamine
metabolism in catechol-O-methyltransferase (COMT)-deficient mice.The European journal of neuroscience . Jan 2002;15(2):246-56.
22. Oner T, Guven B, Tavli V, Mese T, Yilmazer MM, Demirpence S.
Postural Orthostatic Tachycardia Syndrome (POTS) and Vitamin B-12
Deficiency in Adolescents. Pediatrics . Jan 2014;133(1):E138-E142.
doi:10.1542/peds.2012-3427
23. Pektas A, Koken R, Koca HB. Serum vitamin B-12 in children
presenting with vasovagal syncope. Article. Asia Pacific Journal
of Clinical Nutrition . 2018;27(1):176-181. doi:10.6133/apjcn.022017.17
24. Parekh S, Sastry B, Narasimhan C, Arora HJJC. To study vitamin B12
deficiency and response to treatment in patients presenting with
vasovagal syncope. 2018;2(5):000134.
25. Sadeghian S, Aminorroaya A, Tajdini M. The Syncope Unit of Tehran
Heart Center. European Heart Journal . 2020;42(2):148-150.
doi:10.1093/eurheartj/ehaa532 %J European Heart Journal
26. Poorhosseini H, Abbasi SH. The Tehran Heart Center. European
Heart Journal . 2018;39(29):2695-2696. doi:10.1093/eurheartj/ehy369 %J
European Heart Journal
27. Shafiee A, Saadat S, Shahmansouri N, et al. Tehran cohort study
(TeCS) on cardiovascular diseases, injury, and mental health: Design,
methods, and recruitment data. Global Epidemiology . 2021/11/01/
2021;3:100051. doi:https://doi.org/10.1016/j.gloepi.2021.100051
28. Bartoletti A, Alboni P, Ammirati F, et al. ’The Italian Protocol’: a
simplified head-up tilt testing potentiated with oral nitroglycerin to
assess patients with unexplained syncope. Europace : European
pacing, arrhythmias, and cardiac electrophysiology : journal of the
working groups on cardiac pacing, arrhythmias, and cardiac cellular
electrophysiology of the European Society of Cardiology . Oct
2000;2(4):339-42. doi:10.1053/eupc.2000.0125
29. Brignole M, Menozzi C, Del Rosso A, et al. New classification of
haemodynamics of vasovagal syncope: beyond the VASIS
classificationAnalysis of the pre-syncopal phase of the tilt test
without and with nitroglycerin challenge. EP Europace .
2000;2(1):66-76. doi:10.1053/eupc.1999.0064
30. Tajdini M, Aminorroaya A, Tavolinejad H, et al. Atomoxetine as an
adjunct to nonpharmacological treatments for preventing vasovagal
attacks in patients with recurrent vasovagal syncope: A pilot
randomized-controlled trial. IJC Heart & Vasculature .
2021/06/01/ 2021;34:100789.
doi:https://doi.org/10.1016/j.ijcha.2021.100789
31. Iwase S, Nishimura N, Mano T. Role of sympathetic nerve activity in
the process of fainting. Front Physiol . 2014;5:343-343.
doi:10.3389/fphys.2014.00343
32. Sharada K, Reddy G, Narasimhan C. Cobalamin deficiency presenting as
refractory vaso vagal syncope. Letter. International Journal of
Cardiology . 2012;156(1):e7-e8. doi:10.1016/j.ijcard.2011.07.093
33. Ghaznain M, Donnelly TM, Halpenny L. Tilt table test outcome in the
diagnosis and prevalence of syncope in patients with vitamin d and
vitamin B12 deficiency. Age and Ageing . Sep
2017;46doi:10.1093/ageing/afx144.60
34. Aysin E, Urhan M. Dramatic Increase in Dietary Supplement Use During
Covid-19. Current Developments in Nutrition .
2021;5(Supplement_2):207-207. doi:10.1093/cdn/nzab029_008 %J Current
Developments in Nutrition
35. Çimke S, Yıldırım Gürkan D. Determination of interest in vitamin use
during COVID-19 pandemic using Google Trends data: Infodemiology study.Nutrition . 2021;85:111138-111138. doi:10.1016/j.nut.2020.111138
36. Moynihan R, Sanders S, Michaleff ZA, et al. Impact of COVID-19
pandemic on utilisation of healthcare services: a systematic review.
2021;11(3):e045343. doi:10.1136/bmjopen-2020-045343 %J BMJ Open
37. Oh R, Brown DL. Vitamin B12 deficiency. American family
physician . Mar 1 2003;67(5):979-86.